Loading…
Lobbying Spend
—
Filings
61
Firms Hired
1
Active Period
2009–2022
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Health Care Cost Reduction Act of 2012
2012 · second_quarter · Firm: COLBY & COMPANY
HR 436.
Client expense: — · Firm income: —
Matched citations: HR 436
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1260
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1260
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1260
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1427
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1427
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1427
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1548
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1548
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: H.R.1548
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.515
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.515
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.515
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.726
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.726
Promoting Innovation and Access to Life-Saving Medicine Act
2009 · second_quarter · Firm: COLBY & COMPANY
Biosimilars legislation--BioOhio opposed: H.R.1427 (Waxman) and S.726 (Schumer) and supported of H.R.1548 (Eshoo) [letters sent to all members of: House Energy and Commerce; House Judiciary; Senate Health, Education, Labor, and Pensions] Patent reform legislation--BioOhio supported changes to H.R.1260 (Conyers) and supported S.515 (Leahy) as approved by the Senate Judiciary Committee [letters sent to all members of the House Judiciary Committee and Senate Judiciary Committee]
Client expense: — · Firm income: $6,000
Matched citations: S.726
Source: Senate LDA